̷ڻ αǰ 5% ̻ ϰ ִٰ . 4 1 22 αǰ 2.1%(600) 29200 ŷǰ ִ.
ڰÿ ̷ڻ 1 αǰ 5.01%(1707253) ϰ ִٰ . ̷ڻ 1 5% Ѱ űԺ ǹ , 21551ָ 29235 ߰ 峻ż ߴ. αǰ 5% ̻ ̷ڻ ڻ( 5.01%) 2̴.
̷ڻ αǰ δ. þ迡 αǰ پ ߿ ִ. αǰ ̱ ̿ó LSK ̿Ʈʽ(BioPartners) Ƽ(Apatinib Mesylate, 汸 ǥ) ߿ ִ. αǰ ǰ ѱ, Ϻ, DZ ϰ ִ. ̱ Ḯ(Melior Pharmaceuticals) 索ġ(MLR-1023) Բ Ϻ ƽþ DZ ϰ ִ. ̿ܿ 30~40 ǰ ߸Ű Ǿ ִ.
ҹ Ʈ ܼ Ǿǰ(ETC) ߽ δ. ǻ Ʈ Ұ δ Ʈ Ʈ ֹ, ƿ پ å ƴ. αǰ κп ο Ǵܵȴ. ϳǿ αǰ ü ǰ 76.2%, 81% Ǿǰ̴. αǰ ž ؿܿ ǸѴ.
̷ κ ݿ ̷ αǰ ߴ. αǰ 1500 5.9% ٺô. 296 4.2%, 243 3.0% þ ߴ.
Բ ŷµ ִ. αǰ 10Ⱓ ص Ÿ ʰ ؿԴ. ִ 2011 397 2012 416 2013 436 2014 457 ÷Դ. ū ְ ͷ 0.90%( 457 ) ְ, 缺 50% ̻ ϰ ִٴ ҷ Ǵܵȴ.
1б ȯ ݿ αǰ ְ(PER) 42.75. ְڻ(PBR) 4.84, ڱںͷ(ROE) 11.32%.
( 0)